Macquarie Group LTD Embecta Corp. Transaction History

Macquarie Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$21.6 - $30.69 $7,948 - $11,293	-368 Reduced 89.76%	42 $0
Q4 2022 Feb 21, 2023	BUY	$25.29 - $35.48 $1,062 - $1,490	42 Added 11.41%	410 $10,000
Q3 2022 Nov 14, 2022	SELL	$24.0 - $33.42 $1,008 - $1,403	-42 Reduced 10.24%	368 $11,000
Q2 2022 Aug 15, 2022	BUY	$24.78 - $33.36 $10,159 - $13,677	410 New	410 $10,000

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.